System Transmission

Top Signal

100#1 JOB

Activity

2168Ripe

+909 today

System

Live1m

Terminal Asset View

stockNASDAQ

OVID

$1.97-1.99%

Ovid Therapeutics Inc

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

17Overripe

Live Analysis Active

Company Mission

Gathering company mission...

OVI

Industry Context

This company operates in the biotechnology sector, focusing on developing treatments for rare neurological conditions. It competes with other biotech firms by targeting underserved patient populations with high unmet medical needs. The industry is driven by innovation, regulatory approvals, and partnerships with larger drug makers.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

49Matrix

Market Momentum

62.6— Holding Steady

Trend Strength

75— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.6x— Normal Volume

Today's Change

-1.99%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-0

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing OVID across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 03:17 AM UTC

Develops treatments for rare neurological disorders, generating revenue through drug development partnerships and potential future sales.

No technical indicators available, but watch for price action near $2.00 as a key level to gauge investor sentiment in biotech.

Volume data is absent, so monitor if trading activity picks up above average levels to confirm interest in clinical trial updates.

Industry trends favor rare disease treatments, with price needing to hold above support to signal alignment with sector growth.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...